Moti Ramgopal, Midway Research
Midway ResearchDr. Ramgopal is the Founder of Midway Immunology and Research Center and an Associate Professor of Medicine at Florida State University. Dr. Ramgopal is Board Certified and is a Fellow of the American College of Physicians and the Infectious Diseases Society of America.
Presenter Of 1 Presentation
Oral abstract session
OAB0403 - Pooled analysis of 4 international trials of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged >65 or older demonstrating safety and efficacy: Week 48 results
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
Pooled analysis of 4 international trials of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged >65 or older demonstrating safety and efficacy: Week 48 results
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
Pooled analysis of 4 international trials of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults aged >65 or older demonstrating safety and efficacy: Week 48 results
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel